Live Cell Imaging Market

Danaher Corporation (US), Carl Zeiss AG (Germany) and Nikon Corporation (Japan) are leading players in Live Cell Imaging Market

The live cell imaging market is expected to reach USD 2.9 billion by 2023 from an estimated USD 1.9 billion in 2018, at a CAGR of 8.9% during the forecast period (2018–2023). The growing adoption of high-content screening techniques in drug discovery, rising incidence of cancer, and the growth in funding for research are the major factors driving the growth of the global live cell imaging market.

Danaher Corporation (US), Carl Zeiss AG (Germany), Nikon Corporation (Japan), Olympus Corporation (Japan), PerkinElmer, Inc. (US), GE Healthcare (US), Bruker Corporation (US), Thermo Fisher Scientific Inc. (US), Sartorius AG (Germany), BioTek Instruments (US), Etaluma, Inc. (US), CytoSMART Technologies (Netherlands), and NanoEnTek Inc. (Korea) are the major players operating in the live cell imaging market. These players have adopted various growth strategies, such as product launches and enhancements, acquisitions, expansions, contracts, agreements, partnerships, and collaborations. Product launches and enhancements have been the most widely adopted strategies by major players from 2015 to 2018. These strategies helped market players to innovate products and broaden their customer base.

To know about the assumptions considered for the study download the pdf brochure

Danaher dominated the live cell imaging market in 2017. The company is a global leader in live cell imaging and has been operating in the market for about 50 years. Innovation is the prime strength of the company, on the basis of which, Danaher has been able to expand its product portfolio, enter new markets, and build a better network for increasing its customer base. Its innovative capabilities are evident from the products the company has launched in recent years, such as the SP8 FALCON launched in March 2018, which is an integrated contrast microscope that enables researchers to monitor interactions between proteins in living cells. R&D is a key area of focus for Danaher—it invested USD 1.13 billion in R&D activities in 2017. The company focuses on improving its R&D capabilities to unlock additional synergies and growth opportunities.

Carl Zeiss is another dominant player in the live cell imaging market. The leading position of the company is attributed to its brand recognition and its innovative quality products. The company’s Center for Application and Research in Bangalore (India) and the Carl Zeiss Innovations Center for Research and Development in Shanghai (China) strengthened its presence in the rapidly developing economies of the APAC region. Additionally, the company also focuses on entering into collaborative agreements with academic institutions to achieve operational efficiencies, market penetration, and geographic diversification. In March 2017, Carl Zeiss entered into a partnership with Carl R. Woese Institute for Genomic Biology (IGB) (US) to provide researchers around the US with access to the advanced technologies offered by Zeiss including the ZEISS Celldiscoverer 7, at IGB’s Core Facilities.

Nikon is one of the leading players operating in the live cell imaging market. The company operates in Europe, North America, Asia Pacific, and Africa. The firm has subsidiaries in over 81 countries. Nikon has strengthened its position in the market by launching innovative products such as the A1 HD25/A1R HD25 Confocal Microscope, N-SIM S Super Resolution Microscope, and Inverted Research Microscope ECLIPSE Ti2. The company mainly focuses on achieving inorganic growth by entering into agreements with other companies. In February 2018, Nikon Corporation entered into a contract with Berkeley Lights, Inc. (US) to enable Nikon to expand its business presence, market position, and provide new products and services in cell-related fields.

Related Reports:

Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Drug Discovery), End User (Pharmaceutical & Biotechnology Companies, Research Institutes) - Global Forecasts to 2023

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441

Report Code
BT 3390
RI Published ON
Choose License Type
Request Customization
Speak to Analyst
Speak to Analyst
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
  • What are the Known and Unknown Adjacencies Impacting the Live Cell Imaging Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
© MarketsandMarkets Research Private Ltd. All rights reserved